Listen to this article on the DDW Podcast: Following the announcement that Merck & Pfizer’s immunotherapy drug avelumab has been approved by National Institute for Health and Care Excellence (NICE) in the UK, Lu Rahman speaks to Dr Stuart Hill, Medical Director for Merck, about the development of the drug and what this means for the […]